| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.03 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |